Evaluation of analgesic activity of aqueous extract of Mangifera indica leaves in albino rats

Background: Mangifera indica (MI), also known as mango, aam, has been an important herb in the Ayurvedic and indigenous medical systems for over 4000 years. Mangoes belong to genus Mangifera, which consists of about 30 species of tropical fruiting trees in the flowering plant family Anacardiaceae. According to Ayurveda, varied medicinal properties are attributed to different parts of the mango tree. This study was undertaken to evaluate the analgesic activity of aqueous extract of MIleaves in albino rats.Methods: Analgesic activity was evaluated by hot plate method and acetic acid induced writhing with four groups of six rats each. Group 1 was control, Group 2 received standard drug (tramadol and diclofenac for hot plate and writhing method, respectively), and Groups 3 and 4 received aqueous extract of MI leaves extract 200 mg/kg and 400 mg/kg.Results: The reaction time (seconds, mean±standard error mean [SEM]) in hot plate method at 120 mins increased significantly (p<0.001) with MI 200 mg/kg and 400 mg/kg, 8.96±0.12 and 10.61±0.2, respectively. The acetic acid induced writhing test showed a significant (p<0.001) decrease in number of writhes (mean±SEM) in MI 200 mg/kg and 400 mg/kg 43.76±1.59 and 30.33±1.41 respectively in treated rats when compared with control 67.17±0.75.Conclusion: Aqueous extract of MI extract has significant analgesic effect in rats

Evaluation of anti-inflammatory activity of aqueous extract of Mangifera indica leaves in albino rats

Background: Mangifera indica (MI) commonly known as mango belongs to the family anacardiaceae, distributed in rural and semi urban parts of India. According to Ayurveda, various medical properties are attributed to different parts of the mango tree. The purpose of the study was to evaluate anti-inflammatory activity of aqueous extract of Mangifera indica leaves. Methods: Aqueous extract of Mangifera indica leaves was prepared and tested for anti-inflammatory activity in albino rats weighing 200-250 gm. The in vivo anti-inflammatory activity was evaluated by using Acute (carrageenan induced paw edema) and chronic (Formalin induced paw edema) animal models. Rats were divided into 4 groups, 6 rats in each group. Group I (control) received 0.1 ml 4% gum acacia suspension. Group II and Group III received Mangifera indica extract at doses of 200 mg/kg and 400 mg/kg body weight. Group IV (standard) received diclofenac 10 mg/kg body weight. All the drugs were administered orally. Anti-inflammatory activity was expressed as percentage inhibition of paw edema. Results: The percentage inhibition in carrageenan induced paw edema with 200 mg/kg and 400 mg/kg Mangifera indica extract was 44.8% and 53% and in formalin induced paw edema was 47.5% and 64.4% respectively. The two doses of Mangifera indica extract showed significant anti-inflammatory action (p<0.001) in both models. Conclusions: Aqueous extract of Mangifera indica leaves showed significant dose dependent anti-inflammatory activity. [Int J Basic Clin Pharmacol 2016; 5(3.000): 635-638

Embedding Instruments &amp; Modules into an IEEE1451-FPGA-based Weblab Infrastructure

Adopting standard-based weblab infrastructures can be an added value for spreading their influence and acceptance in education. This paper suggests a solution based on the IEEE1451.0 Std. and FPGA technology for creating reconfigurable weblab infrastructures using Instruments and Modules (I&amp;Ms) described through standard Hardware Description Language (HDL) files. It describes a methodology for creating and binding I&amp;Ms into an IEEE1451-module embedded in a FPGA-based board able to be remotely controlled/accessed using IEEE1451-HTTP commands. At the end, an example of a step-motor controller module bond to that IEEE1451-module is described

Congenital rubella syndrome surveillance in India, 2016–21: Analysis of five years surveillance data

Background: In India, facility-based surveillance for congenital rubella syndrome (CRS) was initiated in 2016 to estimate the burden and monitor the progress made in rubella control. We analyzed the surveillance data for 2016–2021 from 14 sentinel sites to describe the epidemiology of CRS. Method: We analyzed the surveillance data to describe the distribution of suspected and laboratory confirmed CRS patients by time, place and person characteristics. We compared clinical signs of laboratory confirmed CRS and discarded case-patients to find independent predictors of CRS using logistic regression analysis and developed a risk prediction model. Results: During 2016–21, surveillance sites enrolled 3940 suspected CRS case-patients (Age 3.5 months, SD: 3.5). About one-fifth (n = 813, 20.6%) were enrolled during newborn examination. Of the suspected CRS patients, 493 (12.5%) had laboratory evidence of rubella infection. The proportion of laboratory confirmed CRS cases declined from 26% in 2017 to 8.7% in 2021. Laboratory confirmed patients had higher odds of having hearing impairment (Odds ratio [OR] = 9.5, 95% confidence interval [CI]: 5.6–16.2), cataract (OR = 7.8, 95% CI: 5.4–11.2), pigmentary retinopathy (OR = 6.7, 95 CI: 3.3–13.6), structural heart defect with hearing impairment (OR = 3.8, 95% CI: 1.2–12.2) and glaucoma (OR = 3.1, 95% CI: 1.2–8.1). Nomogram, along with a web version, was developed. Conclusions: Rubella continues to be a significant public health issue in India. The declining trend of test positivity among suspected CRS case-patients needs to be monitored through continued surveillance in these sentinel sites

Delaying surgery for patients with a previous SARS-CoV-2 infection

Not availabl